GlassScriptPhysician profile
Cora Y Lee
NPI 1982624243
$1,071.15
in general payments reported to CMS, 2019-2025
8 companies · $341 in 2025
The $341 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.81 · 2020: $20.59 · 2021: $195 · 2022: $73.06 · 2023: $90.76 · 2024: $314 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $347.33 | 2019-2025 | Bridion |
| Fisher & Paykel Healthcare INC | $179.05 | 2024-2025 | Fisher & Paykel Healthcare |
| Becton, Dickinson and Company | $148.47 | 2025 | Hemosphere |
| Acacia Pharma INC | $136.25 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $129.97 | 2022-2025 | Exparel, Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $50.88 | 2024-2025 | |
| Edwards Lifesciences Corporation | $42.42 | 2024 | Hemosphere |
| Avadel Cns Pharmaceuticals, LLC | $36.78 | 2025 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cora Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.